Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $624.99 million. The enterprise value is $1.05 billion.
| Market Cap | 624.99M |
| Enterprise Value | 1.05B |
Important Dates
The last earnings date was Wednesday, October 29, 2025, after market close.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 52.52 million shares outstanding. The number of shares has increased by 6.86% in one year.
| Current Share Class | 52.52M |
| Shares Outstanding | 52.52M |
| Shares Change (YoY) | +6.86% |
| Shares Change (QoQ) | +4.24% |
| Owned by Insiders (%) | 2.86% |
| Owned by Institutions (%) | 72.84% |
| Float | 51.02M |
Valuation Ratios
The trailing PE ratio is 8.81 and the forward PE ratio is 4.01.
| PE Ratio | 8.81 |
| Forward PE | 4.01 |
| PS Ratio | 0.81 |
| Forward PS | 2.84 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 4.82 |
| P/FCF Ratio | 446.42 |
| P/OCF Ratio | 48.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.77, with an EV/FCF ratio of 750.35.
| EV / Earnings | 13.84 |
| EV / Sales | 1.33 |
| EV / EBITDA | 4.77 |
| EV / EBIT | 8.48 |
| EV / FCF | 750.35 |
Financial Position
The company has a current ratio of 5.76, with a Debt / Equity ratio of 1.15.
| Current Ratio | 5.76 |
| Quick Ratio | 2.89 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | 3.05 |
| Debt / FCF | 479.29 |
| Interest Coverage | 2.09 |
Financial Efficiency
Return on equity (ROE) is 13.92% and return on invested capital (ROIC) is 6.35%.
| Return on Equity (ROE) | 13.92% |
| Return on Assets (ROA) | 5.27% |
| Return on Invested Capital (ROIC) | 6.35% |
| Return on Capital Employed (ROCE) | 9.35% |
| Revenue Per Employee | $876,556 |
| Profits Per Employee | $84,333 |
| Employee Count | 900 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.19 |
Taxes
In the past 12 months, EBS has paid $30.00 million in taxes.
| Income Tax | 30.00M |
| Effective Tax Rate | 28.33% |
Stock Price Statistics
The stock price has increased by +26.19% in the last 52 weeks. The beta is 2.32, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 2.32 |
| 52-Week Price Change | +26.19% |
| 50-Day Moving Average | 10.11 |
| 200-Day Moving Average | 7.47 |
| Relative Strength Index (RSI) | 62.73 |
| Average Volume (20 Days) | 871,007 |
Short Selling Information
The latest short interest is 9.26 million, so 17.63% of the outstanding shares have been sold short.
| Short Interest | 9.26M |
| Short Previous Month | 8.83M |
| Short % of Shares Out | 17.63% |
| Short % of Float | 18.15% |
| Short Ratio (days to cover) | 6.81 |
Income Statement
In the last 12 months, EBS had revenue of $788.90 million and earned $75.90 million in profits. Earnings per share was $1.35.
| Revenue | 788.90M |
| Gross Profit | 384.30M |
| Operating Income | 123.90M |
| Pretax Income | 105.90M |
| Net Income | 75.90M |
| EBITDA | 220.00M |
| EBIT | 123.90M |
| Earnings Per Share (EPS) | $1.35 |
Balance Sheet
The company has $245.50 million in cash and $671.00 million in debt, giving a net cash position of -$425.50 million or -$8.10 per share.
| Cash & Cash Equivalents | 245.50M |
| Total Debt | 671.00M |
| Net Cash | -425.50M |
| Net Cash Per Share | -$8.10 |
| Equity (Book Value) | 582.50M |
| Book Value Per Share | 11.05 |
| Working Capital | 650.40M |
Cash Flow
In the last 12 months, operating cash flow was $13.00 million and capital expenditures -$11.60 million, giving a free cash flow of $1.40 million.
| Operating Cash Flow | 13.00M |
| Capital Expenditures | -11.60M |
| Free Cash Flow | 1.40M |
| FCF Per Share | $0.03 |
Margins
Gross margin is 48.71%, with operating and profit margins of 15.71% and 9.62%.
| Gross Margin | 48.71% |
| Operating Margin | 15.71% |
| Pretax Margin | 13.42% |
| Profit Margin | 9.62% |
| EBITDA Margin | 27.89% |
| EBIT Margin | 15.71% |
| FCF Margin | 0.18% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.86% |
| Shareholder Yield | -6.86% |
| Earnings Yield | 12.14% |
| FCF Yield | 0.22% |
Analyst Forecast
The average price target for EBS is $15.00, which is 26.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 26.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 4.57% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 1.54 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.54 |
| Piotroski F-Score | 5 |